Lanean...

The Role of Immunotherapy in Multiple Myeloma

Multiple myeloma is the second most common hematologic malignancy. The treatment of this disease has changed considerably over the last two decades with the introduction to the clinical practice of novel agents such as proteasome inhibitors and immunomodulatory drugs. Basic research efforts towards...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pharmaceuticals (Basel)
Egile Nagusiak: Kocoglu, Mehmet, Badros, Ashraf
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2016
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4812367/
https://ncbi.nlm.nih.gov/pubmed/26784207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph9010003
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!